Oncology Medical News about Positron emission tomography

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Positron emission tomography/computed tomography introduction in the clinical management of patients with suspected recurrence of ovarian cancer: a cost-effectiveness analysis
European Journal of Cancer Care, 09/10/09

Mansueto M et al. – Aim of this study was to evaluate the economic impact of the introduction of positron emission tomography/computed tomography (PET/CT) in the early detection of recurrent ovarian cancer through a cost–effectiveness analysis of different diagnostic strategies. Positron emission tomography/computed tomography introduction in this population is cost–effective and allowed to redirect the clinical management of patients towards more appropriate therapeutic choices.

<< Previous
Self-efficacy beliefs and levels of anxiety in advanced cancer...

Next >>
Retreatment with bortezomib alone or in combination for patients...